All Substitutes


Loading...

Disclaimer

Want to know more?
Read Our Editorial Policy

Did you find this information helpful?

    
General Image 1
General Image 2
General Image 1
22% Off

Degatide 120mg Injection

Prescription Required

cold-chain

Salt Composition : Degarelix

Manufacturer : CIPLA LTD

Origin of Medicine : India

MRP: 18000
Price :13962
You Save :4038 (22%)

1 Vial(s)

Prepaid Only. Non-Returnable
Out of Stock

PAP Information :    Contact us for latest updates.

Pincode
Delivery By -

Patient Assistance Programs
Know About PAP

Program Overview: CIPLA LTD, Patient Assistance Program (PAP), is dedicated to helping patients in need of Degatide 120mg injection. The program aims to provide eligible patients with access to the medication at a more affordable cost.

Program Benefits: Patient assistance programs (PAPs) are sponsored by pharmaceutical companies and are an important step toward lowering overall therapy costs for patients. The purpose of these initiatives is to provide financial assistance to patients so they can obtain drugs at low or no cost. MrMed will guide you through the procedure and ensure you receive your PAP medication correctly. 

Contact us for the latest updates on this exclusive offer. 

Eligibility Criteria: To qualify for Degatide Patient Assistance Program (PAP), you must meet specific criteria, including having a valid prescription for Degatide 120mg from a medical oncologist and being an Indian patient with a valid identity card. Eligibility is determined based on the diagnosed condition and program-specific requirements.

Contact Information: If you have any questions or need assistance with the application process, our dedicated patient support team is here to help. You can reach us by phone at 89391 69999 or email us at [email protected].

Please note that MrMed is not involved in the PAP program. They offer free consultations to patients to provide information about the program. Patients eligible for the PAP program by Cipla can avail of it without having to purchase the medication from MrMed.

Patient Assistance Programs

Program Overview: CIPLA LTD, Patient Assistance Program (PAP), is dedicated to helping patients in need of Degatide 120mg injection. The program aims to provide eligible patients with access to the medication at a more affordable cost.

Program Benefits: Patient assistance programs (PAPs) are sponsored by pharmaceutical companies and are an important step toward lowering overall therapy costs for patients. The purpose of these initiatives is to provide financial assistance to patients so they can obtain drugs at low or no cost. MrMed will guide you through the procedure and ensure you receive your PAP medication correctly. 

Contact us for the latest updates on this exclusive offer. 

Eligibility Criteria: To qualify for Degatide Patient Assistance Program (PAP), you must meet specific criteria, including having a valid prescription for Degatide 120mg from a medical oncologist and being an Indian patient with a valid identity card. Eligibility is determined based on the diagnosed condition and program-specific requirements.

Contact Information: If you have any questions or need assistance with the application process, our dedicated patient support team is here to help. You can reach us by phone at 89391 69999 or email us at [email protected].

Please note that MrMed is not involved in the PAP program. They offer free consultations to patients to provide information about the program. Patients eligible for the PAP program by Cipla can avail of it without having to purchase the medication from MrMed.

Introduction to Degatide 120mg Injection

Degatide 120mg injection contains the active ingredient degarelix. It is used to treat advanced prostate cancer. Prostate cancer is cancer that occurs in the prostate (a gland in males that produces seminal fluid). Cancer is a disorder in which cells multiply in an uncontrolled and abnormal manner. 

Contact your doctor immediately if you experience dizziness, fever, or infection. During this treatment, your doctor may periodically monitor your blood pressure, blood sugar, electrolytes, heart, liver, and kidney parameters to prevent serious complications. Report to your doctor if you have been diagnosed with problems in your heart, liver, or kidneys. Patients with severe liver and kidney impairment should exercise caution while using this medicine. This medicine is contraindicated in patients with known hypersensitivity to this drug or to any of the product components.

Degatide 120mg injection has the potential to impair the fertility of males and females of reproductive potential. This injection is not recommended during pregnancy due to its ability to harm the foetus and cause miscarriage. It is not known if this medicine passes into breast milk. Consult your doctor for more advice. Possible side effects related to therapy include redness, swelling, and itching at the injection site. These are usually mild, self-limiting, and decrease within three days.


Uses of Degatide 120mg Injection

  • Advanced prostate cancer

Therapeutic Effects of Degatide 120mg Injection

Degatide 120mg injection directly blocks the effects of a natural hormone (gonadotropin-releasing hormone, GnRH), reduces the level of the male hormone testosterone, and slows down the growth of prostate cancer cells.


Interaction of Degatide 120mg Injection with other drugs

Inform your healthcare provider about all the medicines you take, including prescription medications, over-the-counter medications, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Degatide 120mg injection and reduce effectiveness by causing undesirable side effects. 


More Information about Degatide 120mg Injection

  • Store Degatide 120mg injection in a refrigerator (2°C – 8°C).
  • Do not freeze.
  • Keep it out of reach from children and pets.

How to consume Degatide 120mg Injection

Degatide 120mg injection is available as a prefilled syringe and solution for injection. Your doctor or nurse will administer the injection into the fatty tissues just under your skin (subcutaneously). The dose, route of administration, and frequency will be decided by your doctor based on your disease condition and other factors.


Safety Advices for Degatide 120mg Injection

Image Not Available  

Pregnancy

  

Degatide 120mg injection is unsafe when administered during pregnancy because it may cause birth defects in your baby. Consult your doctor if you are pregnant or planning for pregnancy during the treatment.

Image Not Available  

Breast Feeding

  

It is not known whether Degatide 120mg injection passes into the breastmilk. Consult your doctor for more advice.

Image Not Available  

Lungs

  

It is unknown whether Degatide 120mg injection can be administered to patients with lung problems. Consult your doctor if you have any lung diseases before starting the treatment.

Image Not Available  

Liver

  

It is unknown whether Degatide 120mg injection can be administered in patients with liver disorders. Inform your physician if you have any liver problems before starting treatment with this Injection.

Image Not Available  

Alcohol

  

It is unsafe to consume alcohol with Degatide 120mg injection. Please consult your doctor for more advice.

Image Not Available  

Driving

  

It is unsafe to travel, drive vehicles, or operate heavy machinery after taking (1 hour) Degatide 120mg injection. Please consult your doctor.


Side Effects of Degatide 120mg Injection

Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. 

Common

  • Hot flashes
  • Injection site reactions (redness and pain)
  • Fever, chills
  • Headache, dizziness
  • Trouble sleeping
  • Tiredness
  • Nausea, diarrhea
  • Increased weight
  • Excessive sweating (including night sweats)
  • Anemia
  • Muscle pain and discomfort
  • Breast swelling, reduced size of testicles
  • Decreased sex drive

Word of Advice

Degatide 120mg injection can cause hot flashes, hence it is advised to wear loose-fitting clothes to avoid discomfort. Eat a well-balanced diet. If you feel dizzy or tired, avoid driving or handling machines. Do not touch or rub your skin after injecting this medicine.


FAQs

Q 1. Is Degatide 120mg injection used as a monotherapy to treat cancer?

Degatide 120mg injection is prescribed alone and also with other anti-androgen medications to treat hormonal cancer.

Q 2. Is it safe to use Degatide 120mg injection during pregnancy?

Degatide 120mg injection can harm an unborn baby and result in miscarriage. Hence it is not recommended during pregnancy.

Q 3. How is Degatide 120mg injection administered?

Degatide 120mg injection is administered as a subcutaneous injection (under the skin), usually in the lower abdomen, once every 28 days.

Q 4. What are the common side effects of Degatide 120mg injection?

Injection site reactions, weight gain, chills, hot flashes, hypertension, asthenia, tiredness, fever, constipation, back pain, urinary tract infection, changes in liver enzymes, dizziness, headache, and insomnia are the most common side effects of Degatide 120mg injection.

Q 5. Who should not take Degatide 120mg injection?

Degatide 120mg injection is not recommended for men who have a history of severe allergic reactions to the medication.


Fact Box of Degatide 120mg Injection

Molecule name: Degarelix

Therapeutic class: Antineoplastics

Pharmacological class: Gonadotropin-releasing hormone antagonists

Indications: Advanced prostate cancer


References

  1. Ferring Pharmaceuticals A/S, Electronic medicines compendium (EMC), [ Revised on Dec 2019] [ Accessed on 23rd March 2023], https://www.medicines.org.uk/emc/files/pil.6537.pdf
  2. Ferring Pharmaceuticals Inc, US Food and Drug Administration, [ Revised on Feb 2015] [ Accessed on 23rd March 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022201s009lbl.pdf
  3. Goodman & Gilman’s, The Pharmacological Basis of Therapeutics, Natural products in cancer chemotherapy: Hormones and related agents, 12th edition, 2011, 1764.
  4. Claudine Isaacs, Anton Wellstein, and Anna T. Riegel, Hormones and Related Agents in the Therapy of Cancer, Goodman & Gilman’s Pharmacological Basis of Therapeutics, 13th Edition, 2018, 1237-1247.

Disclaimer

MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.

4000+ products

We maintain strict quality controls on all our partner retailers, so that you always get standard quality products.

Secure Payment

100% secure and trusted payment protection

Easy Return

We have a new and dynamic return window policy for medicines and healthcare items. Refer FAQs section for more details.